BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CRK Clinical Research Key NGO - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CRK Clinical Research Key NGO
X-ORIGINAL-URL:https://clinicalresearchkey.org
X-WR-CALDESC:Events for CRK Clinical Research Key NGO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250308T000000
DTEND;TZID=UTC:20260412T170000
DTSTAMP:20260502T214600
CREATED:20210304T031301Z
LAST-MODIFIED:20250828T123737Z
UID:448-1741392000-1776013200@clinicalresearchkey.org
SUMMARY:Raising Awareness and Promoting Early Diagnosis of ATTR Cardiac Amyloidosis
DESCRIPTION:This educational activity is supported by an independent medical education grant from the Mayo Clinic and Pfizer\, Inc. \nThis CPD-accredited online course is designed to enhance the knowledge\, diagnostic accuracy\, and clinical response of healthcare professionals in Kenya regarding transthyretin (TTR) cardiac amyloidosis\, a serious and underrecognized cause of heart failure. Through an evidence-based and locally contextualized curriculum\, the course empowers clinicians to identify red flags\, select and interpret appropriate diagnostic tools\, and apply best-practice management strategies\, including genetic counseling and advanced imaging. \nParticipants will engage with dynamic learning modules\, animated explainer videos\, expert interviews\, and real-world clinical cases to sharpen diagnostic reasoning and multidisciplinary collaboration. The course also introduces emerging therapies and surveillance strategies tailored to both wild-type and hereditary forms of ATTR-CM. \nWhether you’re a cardiologist\, internal medicine specialist\, radiologist\, lab expert\, or front-line provider\, this course equips you with the tools to ensure earlier diagnosis\, improve patient outcomes\, and bridge critical gaps in care across Kenya. \n Anders Barasa\, MD\, PhD             John Heshmat\, PharmD\, MSc \nWhat Will I Learn?\n\nDescribe the pathophysiology\, subtypes\, and burden of TTR amyloidosis.\nIdentify clinical\, ECG\, and imaging red flags suggestive of ATTR-CM.\nApply diagnostic algorithms using monoclonal protein screening\, bone scintigraphy\, biopsy\, and genetic testing.\nInterpret cardiac MRI and echocardiographic findings relevant to amyloidosis.\nChoose evidence-based therapies and manage mutation carriers.\nAnalyze clinical cases to avoid misdiagnosis and diagnostic delays.\n\nTarget Audience\n\nCardiologists\nGeneral Physicians\nRadiologists\nClinical Officers\nLaboratory and imaging specialists\nICU and internal medicine physicians\nGeneral practitioners and primary care providers\nNurses and pharmacists involved in cardiac care\n\nMaterials Included\n\nAnimated explainer videos\nExpert-led videos and case walk-throughs\nDownloadable clinical algorithms and diagnostic checklists\nAccess to guidelines and summary tables\nPDF reading materials and infographics\nPre- and post-course assessments\nCompletion certificate with CPD credits\nFind Multiple Hotspots Activity\nInteractive Videos (videos enriched with interactions) Activity\nBranching Scenario (dilemmas and self paced learning) Activity
URL:https://clinicalresearchkey.org/event/free-cme-course-cardiac-ttr-amyloidosis-kenya/
LOCATION:CRK Courses Online Plateform\, Kenya
CATEGORIES:Seminars
ATTACH;FMTTYPE=image/webp:https://clinicalresearchkey.org/wp-content/uploads/2021/03/9355472.webp
ORGANIZER;CN="CRK-NGO":MAILTO:info@crkcourses.com
END:VEVENT
END:VCALENDAR